Your browser doesn't support javascript.
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.
Flaxman, Seth; Mishra, Swapnil; Gandy, Axel; Unwin, H Juliette T; Mellan, Thomas A; Coupland, Helen; Whittaker, Charles; Zhu, Harrison; Berah, Tresnia; Eaton, Jeffrey W; Monod, Mélodie; Ghani, Azra C; Donnelly, Christl A; Riley, Steven; Vollmer, Michaela A C; Ferguson, Neil M; Okell, Lucy C; Bhatt, Samir.
  • Flaxman S; Department of Mathematics, Imperial College London, London, UK.
  • Mishra S; MRC Centre for Global Infectious Disease Analysis, Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK.
  • Gandy A; Department of Mathematics, Imperial College London, London, UK.
  • Unwin HJT; MRC Centre for Global Infectious Disease Analysis, Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK.
  • Mellan TA; MRC Centre for Global Infectious Disease Analysis, Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK.
  • Coupland H; MRC Centre for Global Infectious Disease Analysis, Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK.
  • Whittaker C; MRC Centre for Global Infectious Disease Analysis, Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK.
  • Zhu H; Department of Mathematics, Imperial College London, London, UK.
  • Berah T; Department of Mathematics, Imperial College London, London, UK.
  • Eaton JW; MRC Centre for Global Infectious Disease Analysis, Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK.
  • Monod M; Department of Mathematics, Imperial College London, London, UK.
  • Ghani AC; MRC Centre for Global Infectious Disease Analysis, Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK.
  • Donnelly CA; MRC Centre for Global Infectious Disease Analysis, Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK.
  • Riley S; Department of Statistics, University of Oxford, Oxford, UK.
  • Vollmer MAC; MRC Centre for Global Infectious Disease Analysis, Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK.
  • Ferguson NM; MRC Centre for Global Infectious Disease Analysis, Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK.
  • Okell LC; MRC Centre for Global Infectious Disease Analysis, Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK.
  • Bhatt S; MRC Centre for Global Infectious Disease Analysis, Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK.
Nature ; 584(7820): 257-261, 2020 08.
Article in English | MEDLINE | ID: covidwho-582068
ABSTRACT
Following the detection of the new coronavirus1 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its spread outside of China, Europe has experienced large epidemics of coronavirus disease 2019 (COVID-19). In response, many European countries have implemented non-pharmaceutical interventions, such as the closure of schools and national lockdowns. Here we study the effect of major interventions across 11 European countries for the period from the start of the COVID-19 epidemics in February 2020 until 4 May 2020, when lockdowns started to be lifted. Our model calculates backwards from observed deaths to estimate transmission that occurred several weeks previously, allowing for the time lag between infection and death. We use partial pooling of information between countries, with both individual and shared effects on the time-varying reproduction number (Rt). Pooling allows for more information to be used, helps to overcome idiosyncrasies in the data and enables more-timely estimates. Our model relies on fixed estimates of some epidemiological parameters (such as the infection fatality rate), does not include importation or subnational variation and assumes that changes in Rt are an immediate response to interventions rather than gradual changes in behaviour. Amidst the ongoing pandemic, we rely on death data that are incomplete, show systematic biases in reporting and are subject to future consolidation. We estimate that-for all of the countries we consider here-current interventions have been sufficient to drive Rt below 1 (probability Rt < 1.0 is greater than 99%) and achieve control of the epidemic. We estimate that across all 11 countries combined, between 12 and 15 million individuals were infected with SARS-CoV-2 up to 4 May 2020, representing between 3.2% and 4.0% of the population. Our results show that major non-pharmaceutical interventions-and lockdowns in particular-have had a large effect on reducing transmission. Continued intervention should be considered to keep transmission of SARS-CoV-2 under control.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics Type of study: Experimental Studies / Observational study / Prognostic study / Systematic review/Meta Analysis Limits: Humans Country/Region as subject: Europa Language: English Journal: Nature Year: 2020 Document Type: Article Affiliation country: S41586-020-2405-7

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics Type of study: Experimental Studies / Observational study / Prognostic study / Systematic review/Meta Analysis Limits: Humans Country/Region as subject: Europa Language: English Journal: Nature Year: 2020 Document Type: Article Affiliation country: S41586-020-2405-7